Search - tctmd.com

Displaying 1 - 20 of 103

Sort: Relevancy | Date

News Conference News EACTS 2025

SAVR Bests TAVI for 5-Year Survival in Combined RCT, Observational Data

Yael L. Maxwell

October 10, 2025

News Conference News NY Valves 2024

Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR

Todd Neale

June 14, 2024

News Conference News EuroPCR 2024

NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

Michael O'Riordan

May 14, 2024

News Conference News EACTS 2023

AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair

Michael O'Riordan

October 09, 2023

News Conference News CRT 2023

New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR

Yael L. Maxwell

March 03, 2023

News Daily News

Patient Risk, Follow-up Duration Drive SAVR, TAVI Outcomes: Meta-analysis

Todd Neale

January 20, 2023

News Features

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Michael O'Riordan

January 06, 2023

News Daily News

Top Structural Heart News of 2022

L.A. McKeown

January 06, 2023

Presentation TVT 2022

Durability Matters: Results of the High Risk-SURTAVI 5 year outcomes.

Presenter: Joshua Rovin

June 09, 2022

Presentation ACC 2022

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

Presenter: Michael J. Reardon

April 04, 2022

News Conference News ACC 2022

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Michael O'Riordan

April 04, 2022

News Daily News

TCTMD’s Top 10 Most Popular Stories for November 2021

Shelley Wood

November 30, 2021

News Conference News TCT 2021

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

Yael L. Maxwell

November 05, 2021

Presentation TCT 2021

SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk

Presenter: Nicolas Van Mieghem

November 05, 2021

News Conference News TCT 2021

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

Todd Neale

November 05, 2021

News Opinion Editor's Corner TCT 2021

In-Person and Online: TCT to Showcase Imaging, Valves, DCBs, and More

Shelley Wood

November 01, 2021

News Daily News

Infective Endocarditis Rare After AVR, but Often a Killer When It Occurs

Michael O'Riordan

October 01, 2021

News Daily News

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

Caitlin E. Cox

December 23, 2020

Presentation TCT 2020

TCT 125: TAVR with a Supra-Annular, Self-Expandable Valve in Intermediate Risk Patients: Follow-Up From the SURTAVI Randomized Trial and Continued Access Registry

Presenter: Paul Mahoney

October 14, 2020

News Conference News TVT 2019

Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI

Michael O'Riordan

June 17, 2019

Advertisement

SAVR Bests TAVI for 5-Year Survival in Combined RCT, Observational Data

Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR

NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair

New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR

Patient Risk, Follow-up Duration Drive SAVR, TAVI Outcomes: Meta-analysis

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Top Structural Heart News of 2022

Durability Matters: Results of the High Risk-SURTAVI 5 year outcomes.

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

TCTMD’s Top 10 Most Popular Stories for November 2021

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

In-Person and Online: TCT to Showcase Imaging, Valves, DCBs, and More

Infective Endocarditis Rare After AVR, but Often a Killer When It Occurs

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

TCT 125: TAVR with a Supra-Annular, Self-Expandable Valve in Intermediate Risk Patients: Follow-Up From the SURTAVI Randomized Trial and Continued Access Registry

Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content